| Identification | Back Directory | [Name]
SORAFENIB N-OXIDE | [CAS]
583840-03-3 | [Synonyms]
SORAFENIB N-OXIDE
Sorafenib impurities11
Sorafenib impurities172
Sorafenib Impurity 27(Sorafenib N-Oxide)
4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide
4-[4-[[[[4-Chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]phenoxy]-N-Methyl-2-pyridinecarboxaMide 1-Oxide
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 1-oxide
Sorafenib impurity 23/Sorafenib N-Oxide/4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-2-(methylcarbamoyl)pyridine 1-oxide | [Molecular Formula]
C21H16ClF3N4O4 | [MDL Number]
MFCD09841275 | [MOL File]
583840-03-3.mol | [Molecular Weight]
480.82 |
| Chemical Properties | Back Directory | [Melting point ]
220-222oC | [Boiling point ]
591.7±50.0 °C(Predicted) | [density ]
1.45±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO: soluble; Methanol: very slightly soluble, heated | [form ]
A solid | [pka]
12.89±0.70(Predicted) | [color ]
white to off-white | [biological source]
synthetic | [Major Application]
clinical research
general analytical
life science and biopharma
metabolomics | [InChI]
1S/C21H16ClF3N4O4/c1-26-19(30)18-11-15(8-9-29(18)32)33-14-5-2-12(3-6-14)27-20(31)28-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,27,28,31) | [InChIKey]
BQAZCCVUZDIZDC-UHFFFAOYSA-N | [SMILES]
CNC(=O)C1=[N+](C=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)[O-] |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|